References
- Labro MT. Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents. Expert Rev. Anti Infect. Ther.10(3), 319–340 (2012).
- Labro MT. Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents. Expert Rev. Anti Infect. Ther.10(3), 341–357 (2012).
- Cieza RJ, Cao A, Cong Y, Torres AG. Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther.10(3), 391–400 (2012).
- Cunha C, Carvalho A. Host genetics and invasive fungal diseases: towards improved diagnosis and therapy? Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther.10(3), 257–259 (2012).
- Futata EA, Fusaro AE, de Brito CA, Sato MN. The neonatal immune system: immunomodulation of infections in early life. Immunomodulation for GI infections. Expert Rev. Anti Infect. Ther.10(3), 289–298 (2012).
- Goulding J, Snelgrove R, Saldana J et al. “Respiratory infections: do we ever recover?” Proc. Am. Thorac. Soc.4, 618–625 (2007).
- Boettler T, Neto EC, Kalil J, von Herrath M. Can an immune-regulatory vaccine prevent HIV infection? Expert Rev. Anti Infect. Ther.10(3), 299–305 (2012).
- Wisniewski T, Goni F. Could immunomodulation be used to prevent prion diseases? Expert Rev. Anti Infect. Ther.10(3), 307–317 (2012).
- Giamarellos-Bourboulis EJ, Raftogiannis M. The immune response to severe bacterial infections: consequences for therapy. Expert Rev. Anti Infect. Ther.10(3), 369–380 (2012).
- Bourinbaiar AS, Mezentseva MV, Butov DA et al. Immunotherapeutic approaches in tuberculosis therapy: a brief overview. Expert Rev. Anti Infect. Ther.10(3), 381–389 (2012).
- Mukhopadhyay D, Saha P, Chatterjee M. Targets for immunochemotherapy in Leishmaniasis. Expert Rev. Anti Infect. Ther.10(3), 261–264 (2012).
- Hassan T, McKiernan PJ, McElvaney NG, Cryan SA, Greene CM. Therapeutic modulation of microRNA for the treatment of pro-inflammatory lung diseases. Expert Rev. Anti Infect. Ther.10(3), 359–368 (2012).
- Moos V, Schneider T. The role of T cells in the pathogenesis of classical Whipple’s disease. Expert Rev. Anti Infect. Ther.10(3), 253–255 (2012).
- Snelgrove RJ. Pulmonary innate lymphoid cells (ILCs) regulate repair and remodelling after acute lung injury. Expert Rev. Anti Infect. Ther.10(3), 281–284 (2012).